Triveni Bio
Kejie Li has a diverse background in bioinformatics and computational biology, with experience ranging from postdoctoral research to leading computational biology teams in various companies. They have a PhD in Bioinformatics from Purdue University and have been involved in multiple research and teaching roles throughout their career. Currently, Kejie holds a senior director position at Triveni Bio and is actively involved in various professional associations related to pharmaceutical professionals. Their expertise includes developing bioinformatics pipelines, NGS analytics, and building innovation platforms for therapeutic programs.
This person is not in any teams
Triveni Bio
Triveni Bio is a biotech company pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of I&I disorders. The company’s approach establishes proof-of-concept at the earliest stages of drug development. Through a strong understanding of genetics and mechanistic biology, our pipeline is powered for indication expansion where we know we can have the most impact. To learn more, visit www.triveni.bio.